Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Merkel sees more than enough COVID-19 vaccine available in April

Published 02/12/2021, 09:40 AM
Updated 02/12/2021, 09:45 AM
© Reuters. German Chancellor Merkel speaks on government's response to COVID-19 pandemic, in Berlin

BERLIN (Reuters) - Germany will have difficulties making use of all available COVID-19 vaccines in April, Chancellor Angela Merkel said in an interview with broadcaster ZDF on Friday.

Once a 7-day coronavirus incidence of under 35 per 100,000 people is reached, further relaxations beyond the opening of shops may follow, she added.

"For the next opening step after retail, we have to be careful whether we stay stable below 35," Merkel said. "When we have opened up shops and we are ... stable below 35 for two weeks, then we can consider the next step."

The number of new daily infections in Germany has been falling, prompting some regional leaders to push for a timetable to ease the lockdown, which has been in place since mid-December. But concerns are growing about the impact of more infectious variants of the virus on case numbers.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.